Table 4.
Factors associated with overtreatment
| Variables | CIN1 or less (Overtreatment) N=40 | CIN2+ N=138 |
|---|---|---|
| See-and-treat LEEP | 17 (20) | 69 (80) |
| Age (mean, years)* | 37±13 | 32±10 |
| Race | ||
| Caucasian | 23 (25) | 68 (75) |
| Non-Caucasian | 17 (20) | 70 (80) |
| Gravidity (median, IQR) | 4 (2 – 4) | 2 (1 – 4) |
| Age at first intercourse (years) | 16.3±2.8 | 15.7±2.3 |
| Lifetime number of sexual partners (median, IQR) | 6 (5 – 10) | 6 (4 – 10) |
| HPV positive | 18 (19) | 76 (81) |
| HIV positive | 1(13) | 7(88) |
| Cigarette smokers | 16(20) | 65(80) |
| History of prior LEEP | 2 (12) | 15 (88) |
| Method of contraception | ||
| Pill, Patch, Ring, Condom | 3 (10) | 26 (90) |
| LARC | 11 (20) | 44 (80) |
| Sterilization | 7 (20) | 28 (80) |
| No Method | 14 (30) | 33 (70) |
| Time to LEEP from Pap (months) | ||
| <1.5 | 9 (23) | 30 (77) |
| 1.5 – 2.5 | 8 (18) | 37 (82) |
| 2.5 – 5.5 | 14 (27) | 37 (73) |
| >5.5 | 9 (21) | 34 (79) |
Data are n(%) or mean (SD) unless otherwise specified.
% are listed by row.
IQR = interquartile range, HPV = human papillomavirus, HIV = human immunodeficiency virus, LARC = long acting reversible contraception (Depo provera, IUD).
*
For p < 0.05.